are there generic glp-1 drugs List of approved and pending medications glp 1 drug names list
Description
Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide
Evidence-based comparison of retatrutide (GIP/GLP-1/glucagon triple agonist) and survodutide (GLP-1/glucagon dual agonist) for weight loss, MASH, and metabolic disease based on Phase 2 clinical trial data.
Yet, data on their safety and clinical utility during these reproductive windows remain limited
They follow what they hear
No direct causal link has been established between GLP-1R use and increased aspiration risk
While these agents are not recommended during pregnancy, their use in the preconception, periconception, and postpartum periods is increasing
